 |
|
|
|
December 2001 Cover
|
|
The U.S. Food and Drug Administration (FDA) has approved Viread, a new once-daily pill to treat HIV. San Francisco AIDS specialist Dr. Stephan Becker, who treated more than two dozen patients with Viread in clinical
trials prior to federal approval, said the drug reduced HIV levels without the side effects that are common with other drugs. "This is exactly what we had hoped for," said AIDS activist Martin Delaney. "This is going to be an
important drug for AIDS treatment at every stage of the disease." The FDA approved Viread for all patients, including those being treated for the first time. Delaney and others had feared the drug would be limited to those patients
resistant to other treatments. A year's supply of the new drug will cost $4,135.
from the Associated Press
You are not logged in.
No comments yet, but
click here to be the first to comment on this
HIV Digest!
|
|
|
|
|
